-
Something wrong with this record ?
Synthesis and evaluation of cytotoxic and Na+/K+-ATP-ase inhibitory activity of selected 5α-oleandrigenin derivatives
K. Michalak, L. Rárová, M. Kubala, P. Čechová, M. Strnad, J. Wicha,
European journal of medicinal chemistry.
2019 ;
180 (-) :
417-429.
[pub] 20190709
Language English Country France
Document type Journal Article
Persistent link
https://www.medvik.cz/link/bmc19044649
- MeSH
- Cell Line MeSH
- Antineoplastic Agents, Phytogenic chemical synthesis chemistry pharmacology MeSH
- Enzyme Inhibitors chemical synthesis chemistry pharmacology MeSH
- Cardenolides chemical synthesis chemistry pharmacology MeSH
- Humans MeSH
- Molecular Conformation MeSH
- Nerium chemistry MeSH
- Cell Proliferation drug effects MeSH
- Drug Screening Assays, Antitumor MeSH
- Sodium-Potassium-Exchanging ATPase antagonists & inhibitors metabolism MeSH
- Dose-Response Relationship, Drug MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Oleandrin, the major biologically active constituent of shrub Nerium oleander preparations of which have been used in traditional Mediterranean and Asian medicine, attracts a great deal of attention due to its pronounced anticancer activity. The synthesis of oleandrigenin model, 16β-hydroxy-3β-methoxy-5α-card-20(22)-enolide 16-acetate, from androstenolone acetate through 17β-(3-furyl)-intermediates has been developed. Several related 17β-(butenolidyl)- and 17β-(furyl)-androstane derivatives were synthesized and tested for in vitro cytotoxic and Na+/K+-ATP-ase inhibitory activities. Comparison of Na+/K+-ATP-ase inhibitory and cytotoxic activity underlines complex nature of the relationship.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044649
- 003
- CZ-PrNML
- 005
- 20200113081123.0
- 007
- ta
- 008
- 200109s2019 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejmech.2019.07.028 $2 doi
- 035 __
- $a (PubMed)31325787
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Michalak, Karol $u Institute of Organic Chemistry, Polish Academy of Sciences, ul. Marcina Kasprzaka 44/52, 01-224, Warsaw, Poland.
- 245 10
- $a Synthesis and evaluation of cytotoxic and Na+/K+-ATP-ase inhibitory activity of selected 5α-oleandrigenin derivatives / $c K. Michalak, L. Rárová, M. Kubala, P. Čechová, M. Strnad, J. Wicha,
- 520 9_
- $a Oleandrin, the major biologically active constituent of shrub Nerium oleander preparations of which have been used in traditional Mediterranean and Asian medicine, attracts a great deal of attention due to its pronounced anticancer activity. The synthesis of oleandrigenin model, 16β-hydroxy-3β-methoxy-5α-card-20(22)-enolide 16-acetate, from androstenolone acetate through 17β-(3-furyl)-intermediates has been developed. Several related 17β-(butenolidyl)- and 17β-(furyl)-androstane derivatives were synthesized and tested for in vitro cytotoxic and Na+/K+-ATP-ase inhibitory activities. Comparison of Na+/K+-ATP-ase inhibitory and cytotoxic activity underlines complex nature of the relationship.
- 650 _2
- $a fytogenní protinádorové látky $x chemická syntéza $x chemie $x farmakologie $7 D000972
- 650 _2
- $a kardenolidy $x chemická syntéza $x chemie $x farmakologie $7 D002298
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 _2
- $a inhibitory enzymů $x chemická syntéza $x chemie $x farmakologie $7 D004791
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a Nerium $x chemie $7 D030007
- 650 _2
- $a sodíko-draslíková ATPasa $x antagonisté a inhibitory $x metabolismus $7 D000254
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rárová, Lucie $u Laboratory of Growth Regulators, Institute of Experimental Botany ASCR & Palacky University, Šlechtitelů 27, 783 71, Olomouc, Czech Republic.
- 700 1_
- $a Kubala, Martin $u Department of Biophysics, Faculty of Science, Palacky University, Šlechtitelů 27, 783 71, Olomouc, Czech Republic; Department of Experimental Physics, Faculty of Science, Palacky University, 17. listopadu 12, 771 46, Olomouc, Czech Republic.
- 700 1_
- $a Čechová, Petra $u Department of Biophysics, Faculty of Science, Palacky University, Šlechtitelů 27, 783 71, Olomouc, Czech Republic; Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacky University, 17. listopadu 12, 771 46, Olomouc, Czech Republic.
- 700 1_
- $a Strnad, Miroslav $u Laboratory of Growth Regulators, Institute of Experimental Botany ASCR & Palacky University, Šlechtitelů 27, 783 71, Olomouc, Czech Republic. Electronic address: miroslav.strnad@upol.cz.
- 700 1_
- $a Wicha, Jerzy $u Institute of Organic Chemistry, Polish Academy of Sciences, ul. Marcina Kasprzaka 44/52, 01-224, Warsaw, Poland. Electronic address: jerzy.wicha@icho.edu.pl.
- 773 0_
- $w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 180, č. - (2019), s. 417-429
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31325787 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113081455 $b ABA008
- 999 __
- $a ok $b bmc $g 1482918 $s 1083322
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 180 $c - $d 417-429 $e 20190709 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
- LZP __
- $a Pubmed-20200109
